IRIDEX Corp. (IRIX)

4.43
NASDAQ : Health Technology
Prev Close 4.68
Day Low/High 4.41 / 4.65
52 Wk Low/High 3.72 / 9.48
Avg Volume 34.90K
Exchange NASDAQ
Shares Outstanding 13.59M
Market Cap 63.62M
EPS -1.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Iridex Eyes BRICs To Laser Ahead

Iridex Eyes BRICs To Laser Ahead

The growth of laser eye surgery in emerging markets offers huge opportunities for Iridex, says the company's CFO James Mackaness.

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation (Nasdaq:IRIX) has been downgraded by TheStreet Ratings from from a buy to hold.

Ratings Changes To Be Publicly Issued on 5/31/13

Upgrades: ALJ, APWC, EXH, GTN.A, HCOM, LIWA, MOBI, OSTK, SWFT, TMS, VOC Downgrades: ACU, ADK, AXR, BRP, BXE, CAP, CITZ, CLMS, CRWN, CTIB, CVTI, DAVE, DYNT, EDGW, EMMS, ESTE, HTCO, IRIX, LMIA, LNBB, MASC, MCBI, MHH, MOC, NBBC, NOVB, NWPX, PMBC, PNRG, PZZI, RBCAA, RCKY, STRN, SYNL, TOWR, TWIN, UBCP, UMPQ, USAP, WLFC Initiations: AQ, IMMY Read on to get TheStreet Quant Ratings' detailed report:

Iridex Corporation Stock Upgraded (IRIX)

Iridex Corporation Stock Upgraded (IRIX)

Iridex Corporation (Nasdaq:IRIX) has been upgraded by TheStreet Ratings from a hold to buy.

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation (Nasdaq:IRIX) has been downgraded by TheStreet Ratings from from a buy to hold.

Iridex Corporation Stock Upgraded (IRIX)

Iridex Corporation Stock Upgraded (IRIX)

Iridex Corporation (Nasdaq:IRIX) has been upgraded by TheStreet Ratings from a hold to buy.

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation (Nasdaq:IRIX) has been downgraded by TheStreet Ratings from from a buy to hold.

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation Stock Downgraded (IRIX)

Iridex Corporation (Nasdaq:IRIX) has been downgraded by TheStreet Ratings from from a buy to hold.

8 Health Care Penny Stocks to Buy Now

All it takes is one big drug approval, a buyout from big pharma or a plump contract from a major provider to send shares of penny stocks like these soaring.

Tuesday's Small-Cap Winners & Losers

Health stocks such as Adolor and Advancis Pharmaceutical lead small-cap movers.

Tuesday's Small-Cap Winners & Losers

Layne Christensen climbs higher on a quarterly earnings beat.

American Medical Selling Unit

The deal is worth up to $37 million.

Eyetech Jumps on FDA OK

Eyetech Jumps on FDA OK

The company wins regulatory approval for its vision loss drug Macugen.

Eyetech Gains Despite Loss

Eyetech Gains Despite Loss

Hopes are high that regulators will approve the company's vision treatment in December.

Health Stocks in Motion

Health Stocks in Motion

McKesson surges on earnings surprise.

TheStreet Quant Rating: D (Sell)